Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 11/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 3/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17172289 | 0.91 | CYP3A4 (0.42) | CYP3A4CYP2C9CYP2C19ABL1KCNH2 | |
| SCHEMBL17157372 | 0.89 | DGAT1 (0.37) | CYP3A4CYP2C9CYP2C19DGAT1TRPV3 | |
| SCHEMBL17177016 | 0.89 | DGAT1 (0.34) | ALOX5APRXFP1DGAT1TRPV3 | |
| SCHEMBL17177083 | 0.87 | DGAT1 (0.33) | ALOX5APRXFP1DGAT1TRPV3 | |
| SCHEMBL17172317 | 0.87 | CYP3A4 (0.36) | CYP3A4CYP2C9CYP2C19ABL1DGAT1 | |
| SCHEMBL17196186 | 0.87 | DGAT1 (0.37) | ALOX5APRXFP1DGAT1 | |
| SCHEMBL17172332 | 0.85 | SCN5A (0.38) | CYP3A4CYP2C9CYP2C19ABL1KCNH2 | |
| SCHEMBL17172310 | 0.85 | ALOX5AP (0.41) | CYP3A4CYP2C9CYP2C19ABL1ALOX5AP | |
| SCHEMBL17157410 | 0.83 | ABL1 (0.38) | CYP3A4CYP2C9CYP2C19ABL1ALOX5AP | |
| SCHEMBL17172295 | 0.83 | PDE10A (0.39) | KCNH2TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167300-B2 | Metalloenzyme inhibitor compounds as fungicides | DOW AGROSCIENCES LLC (US) | 2019-01-01 | — | — | US | disclosed |
| US-9944664-B2 | Metalloenzyme inhibitor compounds as fungicides | DOW AGROSCIENCES LLC (US) | 2018-04-17 | — | — | US | disclosed |
| WO-2015160665-A1 | METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2015-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167300-B2 | Metalloenzyme inhibitor compounds as fungicides | GPX1, POR, MGAM | CYP3A4 89/4885CYP2C9 68/4885CYP2C19 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.